CClinicalTrials.gg
CompletedNCT01332825Updated Dec 12, 2013

cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose

An interventional study of saline nasal irrigation in Olfactory Disorder, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-12-12.

Sponsored by University of Washington · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to determine the normal distribution of nasal tissue cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects with smell dysfunction. The investigators will also look at the effect of nasal saline irrigation on olfaction and cAMP levels and if nasal irrigation is capable of harvesting olfactory cilia. The investigators hypothesize that nasal saline will have no effect on olfaction and will be inadequate to harvest olfactory cilia.

Read the detailed description

The investigators will recruit 40 subjects: 10 with olfactory dysfunction and 30 with normal olfaction. The normal olfaction group will be randomized (15-15)to either daily saline nasal irrigation for one week or no irrigation. Normal olfaction subjects will be seen for two visits, olfactory dysfunction for one. All subjects will complete an UPSIT (smell identification test)and a co-morbidity form. All subjects will have a brief nasal exam and then have nasal cells collected by means of a curette on one side and a cytobrush on the other. All subjects will receive Afrin and lidocaine, to improve visualization and for comfort during cell collection. Subjects will then complete a Comfort Scale related to the methods of cell collection. Normal olfaction subjects randomized to nasal irrigation will receive instructions on how to do it and the irrigation results will be collected for analysis along with the nasal cells. At their return visit, normal olfaction subjects will repeat the UPSIT and the comfort scale--all normal olfaction subjects will have a repeat cell collection. Subjects randomized to nasal irrigation will also complete a transition scale which asks if they feel the irrigation made a difference in their sense of smell. Subjects are compensated for time with a gift card.

02

Conditions studied

  • Olfactory Disorder

Keywords

  • olfaction
  • smell dysfunction
03

In context

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Normal olfactory function cohort:

  • self-reported normal smell function
  • age greater than 18 years

Olfactory dysfunction cohort:

  • ICD9 diagnostic code for olfactory dysfunction
  • idiopathic olfactory dysfunction
  • age greater than 18 years

Exclusion criteria

Exclusion Criteria:

  • allergy to lidocaine
  • active upper respiratory infection
  • previous nasal or sinus surgery
  • current tobacco use
  • unable to give consent due to language barrier, cognitive or medical issues
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
41 participants (actual)

Study arms

  • No intervention
    olfactory dysfunction

    subjects diagnosed with olfactory dysfunction

  • No intervention
    normal olfaction, no saline

    no smell dysfunction, not randomized to saline nasal irrigation for 7 days

  • Other
    normal olfaction

    normal olfaction, randomized to saline nasal irrigation for 7 days

    Other: saline nasal irrigation

Interventions

  • Othersaline nasal irrigation

    subjects irrigate with nasal saline daily for one week

06

What researchers measure

Primary outcomes

  1. UPSIT

    validated, scratch and sniff smell identification test

    Time frame: 7 days

07

Study locations

1 site
  • University of Washington
    Seattle, Washington 98105, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01332825
Lead sponsor
University of Washington
Responsible party
Greg Davis (Assistant Professor, University of Washington) — Principal investigator
First posted
Apr 11, 2011
Start date
Mar 2011
Primary completion
Oct 2011
Completion
Dec 2012
Last update
Dec 12, 2013

Study contacts

Greg E Davis, MD, MPH
principal investigator · University of Washington

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion